https://www.selleckchem.com/pr....oducts/cm272-cm-272.
8 months, P0.001). Patients who received chemotherapy showed significantly longer survival than those who did not (13 vs. 7 months, P=0.032). Patients who underwent gastrectomy plus chemotherapy showed better survival than those who underwent other treatments. In multivariate analysis, gastrectomy was found to be an independent prognostic factor (hazard ratio, 0.52; 95% confidence interval, 0.33-0.82) in addition to chemotherapy. Our study showed that patients who underwent gastrectomy plus chemotherapy had the best survival. A